1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Mp0420: new trials by email Literature Review of Mp0420 trials Research Report on Mp0420
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 ensovibep, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | Novartis Pharmaceuticals | 407 | 2021-05-10 | 2026-01-27 |
| Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients ensovibep - Covid19 | Phase 2 | Completed | Molecular Partners AG | 12 | 2021-04-01 | 2021-09-08 |
COVID-19 (2)
Molecular Partners AG (1) · Novartis Pharmaceuticals (1)
Netherlands (2) · Hungary (1) · India (1) · South Africa (1) · United States (1)